Aggregator
When to Trust Epigenetic Clocks: Avoiding False Positives in Aging Interventions
Epigenetic clocks have emerged as potential biomarkers of aging due to their association with morbidity and mortality. They have recently gained traction as outcome measurements for anti-aging interventions. However, as the number of new epigenetic clocks continues to grow, different clocks may not agree on the effect of an intervention. This raises the question of when researchers can trust epigenetic clock results. In this study, we find that when extending previously published single-clock...
Vitamin D Deficiency, Supplementation, and Aging-Related Morbidity and Mortality Across Two Longitudinal Population Cohorts
Vitamin D deficiency has been implicated in biological processes linked to aging and organismal resilience, yet its relationship to long-term systemic aging trajectories remains incompletely characterized. We analyzed longitudinal electronic health record data from two large healthcare systems: Leumit Health Services (LHS), a nationwide Israeli health organization, and TriNetX, a federated US research network. We examined more than 1.67 million serum 25-hydroxyvitamin D [25(OH)D] measurements...
Bacteria turn a virus’ own weapon against it
Researchers have uncovered a new way bacteria detect viral attacks: a virus-produced enzyme cuts a bacterial sensor protein, triggering a self-destructing immune response. The discovery could lead to more effective phage therapies against antibiotic-resistant bacteria and provide insight into ancient immune mechanisms shared with humans.
Daily briefing: Rogue ‘jumping genes’ age bigs dogs faster than little ones
Publisher Correction: Sleep chart of biological ageing clocks in middle and late life
Watch this invisible tattoo appear under UV light
Breaking down nerve-cell scaffold relieves chronic pain in mice
Lymph node contraction links sex-biased naive CD8<sup>+</sup> T cell decline to compromised antigen recognition during middle age
Naive T cell decline limits cancer immunity in middle-aged male mice
Five movements from the edge of the singularity
An experiment to glimpse the future Amazon — in pictures
The life of Darwin and the science of clouds: Books in brief
Chimp and gorilla brains resist weight loss with age — unlike human brains
Briefing Chat: Top researchers are being misled by sham academic societies
U.S. crop genome sequencing gets $180 million boost
Department of Agriculture will expand effort to describe genetics of seed banks
Department of Energy expands ‘Genesis Mission’ to boost AI, awarding larger grants
Department will also initiate new fellowship program to shorten path to Ph.D.
Major employer of archaeologists shuts down, leaving workers in the lurch
The “ungraceful exit” of Chronicle Heritage leaves many researchers fearful for the future
Nearly 30,000 people tested quit-smoking methods. One stood out
Nicotine e-cigarettes appear to help more smokers quit than patches, gum, and several other common approaches, according to a major review of 80 clinical trials. Researchers say regulated vaping products are not risk-free, but may be a significantly less harmful alternative for people who would otherwise continue smoking.
Scientists tested 5 natural compounds on cancer cells. One stood out
Five natural compounds, including curcumin and berberine, were tested for their effects on cancer cells and healthy muscle cells. All disrupted cancer cell energy production and pushed many of the cells into a non-dividing state, with curcumin producing the strongest overall effect. Curcumin also showed a relatively favorable safety profile, while some other compounds caused more toxicity.
FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.